Skip to content
DraconiticResearch
Search Sources API
197,761 studies31 sourcesUpdated 28 min ago
PreprintCC BY-NC-NDbioRxiv

De novo protein design in an expanded chemical space

  1. 1Peking University

Abstract

Generative protein design has made sequence and structure programmable, yet its chemical alphabet remains largely confined to the canonical twenty. Here, we establish CheMoDesign, an experimentally validated generative framework for designing proteins de novo around user-specified chemistry. CheMoDesign weakens pair-representation conditioning in a pretrained all-atom structure-prediction model while preserving chemical anchors, then refines generated backbones through sequence-conditioned denoising. By treating post-translational modifications, synthetic residues, and chemical modifications as user-defined building blocks, the framework generated proteins with chemistry-dependent recognition and reactivity in single-round experimental campaigns. Sulfotyrosine and nitrotyrosine enabled modification-dependent recognition of thrombin and HER2, respectively. Genetically encoded noncanonical residues enabled bioorthogonal affinity switching and light- or proximity-triggered covalent target capture. Post-expression chemical modifications yielded a light-activated covalent PD-L1 binder and an isoform-selective CA IX inhibitor (KD = 45 nM) designed to engage catalytic Zn2+;. CheMoDesign makes chemical mechanism a programmable dimension of de novo protein design.

Related

  1. Bridging MS2 Spectra and Chemical Space: Advances in Spectral Similarity, Molecular Retrieval, and De Novo Structure Discovery
    Julian Pollmann, Roman Bushuiev, Anton Bushuiev +2
    ChemRxivPreprintCC BYFull textMolecular biology & gene regulationChemRxiv
  2. De novo Rubisco design with protein language models
    A. J. Kehl, S. K. S. Chu, J. H. Pereira +6
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  3. Aptamers without SELEX: De novo design from protein structure in hours
    Vladislava A. Dolgusheva, Iosif V. Leibin, Natalia O. Kudryashova +14
    Molecular therapy. Nucleic acidsPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMC
  4. EquiDesign: a versatile computational framework for de novo protein sequence design.
    Qiang Gao, Zhongyu Xu, Kai Chen +4
    Briefings in bioinformaticsPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  5. RiboBridge: protein-conditioned de novo RNA binder structure design
    Zhou Zhang, Hanqun Cao, Minghao Sun +5
    arXivPreprintCC BY 4.0Full textBiophysicsarXiv
BibTeX
@misc{li2026novo,
  title = {{De novo protein design in an expanded chemical space}},
  author = {Y. Li and Y. Jing and Y. Su and W. Ren and J. Zhang and T. Liu},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.08.757794},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.08.757794v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - De novo protein design in an expanded chemical space
AU  - Y. Li
AU  - Y. Jing
AU  - Y. Su
AU  - W. Ren
AU  - J. Zhang
AU  - T. Liu
PY  - 2026
DA  - 2026/10/08
PB  - bioRxiv
DO  - 10.64898/2026.10.08.757794
UR  - https://www.biorxiv.org/content/10.64898/2026.10.08.757794v1
AB  - Generative protein design has made sequence and structure programmable, yet its chemical alphabet remains largely confined to the canonical twenty. Here, we establish CheMoDesign, an experimentally validated generative framework for designing proteins de novo around user-specified chemistry. CheMoDesign weakens pair-representation conditioning in a pretrained all-atom structure-prediction model while preserving chemical anchors, then refines generated backbones through sequence-conditioned denoising. By treating post-translational modifications, synthetic residues, and chemical modifications as user-defined building blocks, the framework generated proteins with chemistry-dependent recognition and reactivity in single-round experimental campaigns. Sulfotyrosine and nitrotyrosine enabled modification-dependent recognition of thrombin and HER2, respectively. Genetically encoded noncanonical residues enabled bioorthogonal affinity switching and light- or proximity-triggered covalent target capture. Post-expression chemical modifications yielded a light-activated covalent PD-L1 binder and an isoform-selective CA IX inhibitor (KD = 45 nM) designed to engage catalytic Zn2+;. CheMoDesign makes chemical mechanism a programmable dimension of de novo protein design.
ER  -